News

The Manila Times3d
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIEN® for Use in Patients with Diabetic Macular Edema (DME)
Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...
Healio2d
Trastuzumab deruxtecan shows ‘encouraging real-world outcomes’ for metastatic breast cancer
Researchers who conducted a real-world analysis of trastuzumab deruxtecan found the drug to be effective in treating metastatic breast cancer, though survival outcomes did not reach clinical trial ...
FDA appoints George Tidmarsh as top drug regulator
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
FDA names former pharmaceutical company executive to oversee US drug program
FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
What's behind a spike in adverse event reports for Vyvanse, Australia's biggest ADHD drug?
Australia's pharmaceuticals watchdog is investigating a spike in adverse event reports for Vyvanse, the country's most ...
Healio5d
FDA names Stanford professor Tidmarsh director of Center for Drug Evaluation and Research
The FDA appointed George F. Tidmarsh, MD, PhD, the director of the Center for Drug Evaluation and Research, the agency announced on Monday.Tidmarsh, an adjunct professor of pediatrics and neonatology ...
The BMJ5d
Malnutrition with use of GLP-1 agonists is an underestimated real world harm
Wraparound care for patients taking GLP-1 agonists must include assessment of nutritional status to identify the risk of malnutrition, writes Ellen Fallows Food insecurity is increasing, particularly ...